Navigation Links
Preview of oral presentations at the 1st IOF-ESCEO Pre-Clinical Symposium
Date:2/23/2011

Registrants to the largest European clinical and research bone meeting - the European Congress on Osteoporosis & Osteoarthritis (ECCEO11-IOF) from March 23-26, 2011 - will receive free registration to the 1st IOF-ESCEO Pre-Clinical Symposium from March 22-23.

The IOF-ESCEO Pre-Clinical Symposium showcases new research at the cutting edge of basic and translational bone science. It will feature:

  • Eight plenary lectures by speakers E. Wagner, J.-P. David, A. Teti, Ph. Clzardin, M. Kassem, P. Bianco, T. Schinke and G. Karsenty
  • Meet-the-Faculty sessions: How to write a grant, C. Cooper; How to write a manuscript, G. Karsenty; How to build up a lecture, E. Wagner; Women in academic careers, A. Teti
  • Twenty-eight selected oral presentations (7 hours!).

Here's a sneak preview of 10 of the 28 orals and speakers:

  • DLK1/FA1 regulates the early chondrogenesis during embryonic endochondral bone formation process and its expression is modulated by TGF-β1 signaling pathway - B. Abdallah

  • Genetic variation in the LRP4 gene influences bone mineral density and hip geometry while missense mutations cause sclerosteosis - E. Piters

  • Sclerostin antibody treatment enhances fracture healing and increases bone mass and strength in non-fractured bones in an adult rat closed femoral fracture model - H. Ke

  • Genome wide association study identifies seven loci that account for 86% of the population attributable risk of paget's disease of bone - O. Albagha

  • Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor - J. Tuckermann

  • MicroRNA-138 targets focal adhesion kinase and regulates In Vivo - M. Kassem

  • Control of bone resorption by semaphorin 4D is dependent on ovarian function - I. Machuca-Gayet

  • Iron overload stimulates osteoclast differentiation of murine osteoclast progenitor RAW 264.7 Through the production of reactive oxygen species - J. Peng

  • MHC class II transactivator: a novel regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity - S. Cenci

  • Strontium ranelate inhibits key factors affecting bone remodelling in human osteoarthritic subchondral bone osteoblasts - J. Martel-Pelletier

Visit http://www.ecceo11-iof.org/pre-clinical-symposium for the complete list of 28 oral presentations and 8 plenary lectures.

We look forward to seeing you in Valencia! www.ecceo11-iof.org


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Related biology news :

1. Innerscope Research(R) Uses Same-Day Results From Biometric Study to Identify Key Themes, Styles Behind Effective, Engaging Speaker Presentations
2. Announcing the 1st IOF-ESCEO Pre-Clinical Symposium
3. Symposium to provide forum for best pre-clinical and translational bone research
4. A missing enzyme conveys major heart protection in pre-clinical work
5. Alzheimers disease therapeutic prevents long-term damage from TBI in pre-clinical studies
6. AAAS Symposium: New research facilitates scientific knowledge transfer
7. WidePoint Corporation Sponsors Identity Protection and Management Symposium, February 3, 2011
8. WidePoint Corporation Sponsors Identity Protection and Management Symposium, February 3, 2011
9. Oil spill symposium to convene scientists, media, policymakers and community leaders
10. Graduate physics students wins top honors in superconductivity symposium
11. Symposium marks milestones in honey bee management, research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
Breaking Biology Technology: